FRANCIS HUSSEY: Open Payments
NPI 1588663595 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 45 payments from 18 companies in 2025. Trend: 2023 $444 · 2024 $878 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $273 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| PFIZER INC. | 4 | $77 |
| Almatica Pharma LLC | 4 | $60 |
| MML US, Inc. | 1 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Cala Health, Inc. | 2 | $36 |
| Radius Health, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $35 |
Products named: UBRELVY, XTAMPZA, NURTEC ODT, QULIPTA, VRAYLAR, TERIPARATIDE, ReActiv8, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
